Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

M James Daly


  • Director at Acadia Pharmaceuticals Inc (ACAD), 2019-09-11
  • Director at Madrigal Pharmaceuticals Inc. (MDGL), 2019-07-01
  • Director at Chimerix Inc (CMRX), 2019-06-24
  • Director at Bellicum Pharmaceuticals Inc (BLCM), 2019-06-14
  • Director at Halozyme Therapeutics Inc (HALO), 2019-05-03
  • Evp, Chief Commercial Officer at Incyte Corp (INCY), 2015-06-25
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $38.39 400 Director 0 2019-09-09 Filing
ACAD $37.79 29,600 Director 400 2019-09-09 Filing
INCY $107.84 981 Officer 3,521 2015-06-23 Filing
INCY $108.28 10,710 Officer 3,521 2015-06-23 Filing
INCY $106.00 981 Officer 3,521 2015-05-26 Filing